Actavis Totowa LLC announced the voluntary recall of Digitek®
Actavis Totowa LLC announced the voluntary recall of Digitek® (digoxin) for all tablets under both the “Bertek” and “UDL” label because these brands may have been dispensed with tablets double the correct thickness resulting in double the labeled strength.
According to the FDA website,
“The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can result from excessive Digitalis intake. Several reports of illnesses and injuries have been received.”
Further information about this recall is available at:
|